Refine my results

Language

Université de Fribourg

The Role of Clusters in the Global Innovation Strategy of MNEs : Theoretical Foundations and Evidence from the Basel Pharmaceutical Cluster

Gugler, Philippe ; Keller, Michael ; Tinguely, Xavier

In: Competitiveness Review, 2015, vol. 25, no. 3, p. 324-340

Purpose – This paper aims to focus on the role of clusters as home and host country- specific advantages for multinational enterprises (“MNEs”) in the organization of their internal and external networks to optimize the diffusion and generation of new knowledge. Strategic asset-seeking investment has been a major driver of the internalization of innovation activities performed by MNEs...

Université de Fribourg

Technology-Sourcing Investment Abroad as an Enhancer of Chinese MNEs’ Innovative Capabilities

Gugler, Philippe ; Vanoli, Laura

In: International Journal of Emerging Markets, 2015, vol. 10, no. 2, p. 243-271

Purpose – The purpose of this paper is to focus on Chinese firms’ innovation processes that are induced by foreign direct investment abroad. The study uses a patent and citation analysis to examine the extent to which investments abroad contribute to enhancing these firms’ innovative capabilities. More specifically, this study focusses on the role of foreign location competitiveness as...

Consortium of Swiss Academic Libraries

Long-term Relationships: Static Gains and Dynamic Inefficiencies

Hémous, David ; Olsen, Morten

In: Journal of the European Economic Association, 2018, vol. 16, no. 2, p. 383-435

Consortium of Swiss Academic Libraries

The Impact of Environmentally Friendly Innovations on Value Added

Soltmann, Christian ; Stucki, Tobias ; Woerter, Martin

In: Environmental and Resource Economics, 2015, vol. 62, no. 3, p. 457-479

Université de Fribourg

The patent buyout price for human papilloma virus (HPV) vaccine and the ratio of R&D costs to the patent value

Songane, Mario ; Grossmann, Volker

In: PLOS One, 2021, p. 1-22

Human papillomavirus (HPV) is responsible for almost all of the 570,000 new cases of cervical cancer and approximately 311,000 deaths per year. HPV vaccination is an integral component of the World Health Organization’s (WHO) global strategy to fight the disease. However, high vaccine prices enforced through patent protection are limiting vaccine expansion, particularly in low- and...

Università della Svizzera italiana

Just-in-time information retrieval and summarization for personal assistance

Bahrainian, Seyed Ali ; Crestani, Fabio (Dir.)

Thèse de doctorat : Università della Svizzera italiana, 2019 ; 2019INFO014.

With the rapid development of means for producing user-generated data opportunities for collecting such data over a time-line and utilizing it for various human-aid applications are more than ever. Wearable and mobile data capture devices as well as many online data channels such as search engines are all examples of means of user data collection. Such user data could be utilized to model user...

Université de Fribourg

The patent buyout price for Human Papilloma Virus (HPV) vaccine and the ratio of R&D costs to the patent value

Songane, Mario ; Grossmann, Volker

(Working Papers SES ; 510)

Human papillomavirus (HPV) is responsible for almost all of the 530,000 new cases of cervical cancer and approximately 266,000 deaths per year. HPV vaccination is an integral component of the World Health Organization’s global strategy to fight the disease. However, high vaccine prices enforced through patent protection are limiting vaccine expansion, particularly in low- and middle-income...

Université de Fribourg

Patenting government funded innovations as a strategy to increase budget for academic vaccine R&D

Songane, Mario

(Working Papers SES ; 509)

Vaccine development is a lengthy, expensive and risky venture, with the research and development (R&D) process costing billions of dollars. The pre-clinical stage of vaccine R&D is largely performed by academic research institutions, then continued by the pharmaceutical industry though licensing agreements, taking the most promising candidates to the clinical testing stage. Governments play a...